Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02257996
Other study ID # SBPP-1
Secondary ID
Status Not yet recruiting
Phase N/A
First received September 24, 2014
Last updated January 14, 2015
Start date August 2015
Est. completion date October 2017

Study information

Verified date January 2015
Source University of Sao Paulo
Contact Claudia CA Siqueira, MSc
Phone +5511985885778
Email claudiacatao@usp.br
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

Objective: To evaluate the effectiveness of online systematic brief psychodynamic psychotherapy (SBPP) via HIPAA compliant web conferencing on adults with neurotic disorders.

Design: Randomized controlled trial. Single blind.

Setting: Internet users in the community, in São Paulo, Brazil.

Participants: Thirty-two adults will be randomly allocated to a group will receive online systematic brief psychodynamic psychotherapy (n=16), or a waiting list group (n=16).

Method: Systematic adaptative diagnosis system will be applied in both groups at pre-treatment and post-treatment (or post-waiting list). Assessment will be a comparison of the adaptative diagnosis evolution between groups.

Primary Outcomes: The subjects treated with online brief systematic psychodynamic psychotherapy will present an increase in their adaptative efficacy measured by systematic adaptative diagnosis scale (SADS) in comparison to the waiting list group, when contrasting their initial and final adaptative diagnostics.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 32
Est. completion date October 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender Both
Age group 22 Years to 65 Years
Eligibility Inclusion Criteria:

- Residents in Sao Paulo city,

- Graduation complete or in course,

- Fluent Portuguese,

- Basic skills on english language,

- If in psychiatric treatment, must be under treatment with stable dosage of psychiatric medication for at least 6 months,

- Participants with diagnosis of neurotic disorders (F03.650),

- Motivation for the therapeutic process,

- Availability for 4 months of psychotherapy,

- A personal computer (with an IP address), a web camera, a microphone, access to a 1 Mbps internet connection and specific computer configuration to access the Secure Psychotherapy Virtual Environment,

- Basic knowledge of elementary internet tools,

- A justified reason that impedes a in person psychotherapy, such as the ones below:

- Lack of financial resources,

- Frequent change of address due to work reasons,

- Mobility restrictions related to accidents, illnesses or physical deficiencies,

- Inability to arrive for psychotherapy appointments due to urban chaos.

Exclusion Criteria:

Participants that present:

- a schizophrenia diagnostic or any other severe mental illness,

- drug and alcohol dependence that are in abstinence from substance abuse,

- untreated diagnosis of illnesses that may cause emotional imbalance, such as thyroid malfunction,

- Participants that are undergoing a therapeutic process during the time of the research,

- Individuals with both suicidal ideation and clear intent and need emergency treatment,

- Participants do not possess the characteristics needed to be included in the sample or are bearers of deficiencies that may compromise the treatment mediated by a computer.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Online Systematic Brief Psychodynamic Psychotherapy
Systematic Adaptative Diagnosis System will be applied in both groups at two different times: pre-treatment and post-treatment

Locations

Country Name City State
Brazil Clinical Psychology Department from Institute of Psychology at University of Sao Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Systematic Adaptive Diagnosis Scale (SADS) Participants of interventional group will be followed for the duration of therapeutic process, an expected average of 3 months.
Participants of control group will be followed after waiting-list period, an expected average of 3 months.
Each participant will be followed, an expected average of 3 months. No
See also
  Status Clinical Trial Phase
Completed NCT02308462 - Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Completed NCT00269594 - An Open-Label Study Of Lamictal In Neurotic Excoriation Phase 2